Jim Cramer Rejects UiPath Despite Cheap Valuation, Backs Affirm
Cramer called UiPath cheap but lacking catalysts, endorsed Karman and Affirm, warned on Onto and Nio, and favored Regeneron, Vertex and Amgen over Alnylam
Last updated: 2026-11-21 09:02:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Onto Innovation Inc. (ONTO) operates in the MEASURING & CONTROLLING DEVICES, NEC sector and is listed on NYSE. The stock is currently priced at $170.16, with a market capitalization of $9.62B and a P/E ratio of 63.59. Over the past 52 weeks, its price has ranged from $121.58 to $386.46. This page covers its latest market performance, valuation, price trends and company information.
$9.62B | |
$188.10 | |
$192.10 | |
$166.49 | |
$195.93 | |
1.10M | |
1.02M | |
63.59 | |
$386.46 | |
$121.58 | |
-- | |
2026-09-30 |
Onto Innovation Inc. (ONTO) last closed at $170.16 as of 2026-11-21 00:50:04, down 10.67% ($20.91) from the previous close of $195.93.
During the latest regular trading session, ONTO traded between $166.49 and $192.10, with a volume of 1.10M shares. The closing price was near the lower end and near the lower end of its 52-week range.
ONTO is down 1.12% as of the last close.
Over the past seven days, Onto Innovation Inc. (ONTO) moved from $209.67 to $170.16, representing a decline of 18.84% ($39.51).
The stock traded between $166.45 and $218.75 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.07 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 18.3%
ONTO is currently trading at $170.16, placing it 18.3% of the way from its 52-week low of $121.58 to its 52-week high of $386.46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.
| Industry | MEASURING & CONTROLLING DEVICES, NEC |
| Employees | 1,790 |
| Exchange | NYSE |
| Company Website |
Latest news related to Onto Innovation Inc. and ONTO stock.
Cramer called UiPath cheap but lacking catalysts, endorsed Karman and Affirm, warned on Onto and Nio, and favored Regeneron, Vertex and Amgen over Alnylam
Onto Innovation reported record Q3 revenues of $409.7M (up 87.8% YoY) and non-GAAP EPS of $2.44 (up 165.2%), with a $1.3B backlog supporting growth through mid-2027. However, the stock trades at an 8.2X EV/sales premium and faces risks from 57.1% customer concentration among four clients and rising inventory costs.
Onto Innovation (ONTO) raised its Q4 revenue guidance to $430M-$450M with non-GAAP EPS of $2.59-$2.79, driven by record Q3 results and strong adoption of its Dragonfly G5 and Atlas G6 tools. The company's $1.3B backlog with orders extending into 2028 signals sustained demand from AI-related semiconductor investments in advanced packaging and advanced nodes.
Onto Innovation reported Q3 revenues of $409.7M (up 87.8%) and non-GAAP earnings of $2.44 per share (up 165.2%), with advanced-packaging revenue expected to grow over 80% in 2026. However, the stock trades at an 8.2X EV/sales premium above its historical median, and return on invested capital of 9.7% lags its 10-year average, suggesting investors should exercise selectivity on entry price despite strong growth visibility.
Onto Innovation (ONTO) delivered improved Q3 2026 results with operating cash flow rising to $79M and revenues surging 88% year-over-year to $410M. The company maintains a $1.3B backlog and projects sequential revenue growth through H1 2027. However, nine-month operating cash flow declined to $166.6M from $233.3M due to higher inventories and collection timing. Competitors KLA and Nova also showed strong performance in semiconductor equipment demand.
Eligible investors can buy real shares of Onto Innovation Inc. (ONTO) through MEXC Stocks. Follow these three steps to open a Stocks account, transfer USDT, and place a Stocks order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to ONTO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between ONTO shares and USD.
ONTO Shares to USD
1.00 ONTO shares = 170.162 USD
Calculations are estimates based on the latest available price and are for reference only.